MEUSW
23andMe Holding Co. [MEUSW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MEUSW Stock Summary
In the News
MEUSW Financial details
Company Rating
-
Market Cap
0
Income
-521.97M
Revenue
247.99M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.11
EPS next Y
-
EPS next Q
-
EPS this Y
15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.92%
Revenue last 5Y
-7.44%
Revenue Q/Q
-10.5%
EPS Q/Q
262.5%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-1%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.33-1.74
52W High
+38%
52W Low
+38%
RSI
-
Rel Volume
1.25
Avg Volume
188.43K
Volume
235.96K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
1.38
Change
3.76%
Company Profile
- Volume Average 188.43K
- CEO Ms. Anne Wojcicki
- Headquarters Sunnyvale,CA,US
- IPO Date 2021-06-17
-
Website
http://www.23andme.com 
23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.
